Arcoma AB Statistics

Total Valuation

Arcoma AB has a market cap or net worth of SEK 114.71 million. The enterprise value is 106.52 million.

Market Cap	114.71M
Enterprise Value	106.52M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Arcoma AB has 13.19 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	13.19M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.77%
Owned by Institutions (%)	13.81%
Float	7.17M

Valuation Ratios

The trailing PE ratio is 11.91 and the forward PE ratio is 9.43.

PE Ratio	11.91
Forward PE	9.43
PS Ratio	0.79
PB Ratio	1.87
P/TBV Ratio	1.87
P/FCF Ratio	n/a
P/OCF Ratio	10.03
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	11.06
EV / Sales	0.73
EV / EBITDA	8.50
EV / EBIT	9.03
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.25

Current Ratio	2.25
Quick Ratio	1.15
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	45.36

Financial Efficiency

Return on equity (ROE) is 16.86% and return on invested capital (ROIC) is 12.62%.

Return on Equity (ROE)	16.86%
Return on Assets (ROA)	7.85%
Return on Invested Capital (ROIC)	12.62%
Return on Capital Employed (ROCE)	19.21%
Revenue Per Employee	4.68M
Profits Per Employee	310,613
Employee Count	31
Asset Turnover	1.55
Inventory Turnover	2.85

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.32% in the last 52 weeks. The beta is 0.81, so Arcoma AB's price volatility has been lower than the market average.

Beta (5Y)	0.81
52-Week Price Change	-35.32%
50-Day Moving Average	9.67
200-Day Moving Average	12.23
Relative Strength Index (RSI)	42.46
Average Volume (20 Days)	15,871

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Arcoma AB had revenue of SEK 145.21 million and earned 9.63 million in profits. Earnings per share was 0.73.

Revenue	145.21M
Gross Profit	60.05M
Operating Income	11.79M
Pretax Income	11.85M
Net Income	9.63M
EBITDA	12.54M
EBIT	11.79M
Earnings Per Share (EPS)	0.73

Full Income Statement

Balance Sheet

The company has 8.20 million in cash and n/a in debt, giving a net cash position of 8.20 million or 0.62 per share.

Cash & Cash Equivalents	8.20M
Total Debt	n/a
Net Cash	8.20M
Net Cash Per Share	0.62
Equity (Book Value)	61.38M
Book Value Per Share	4.66
Working Capital	38.49M

Full Balance Sheet

Cash Flow

Operating Cash Flow	11.43M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 41.36%, with operating and profit margins of 8.12% and 6.63%.

Gross Margin	41.36%
Operating Margin	8.12%
Pretax Margin	8.16%
Profit Margin	6.63%
EBITDA Margin	8.63%
EBIT Margin	8.12%
FCF Margin	n/a

Dividends & Yields

Arcoma AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	8.39%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a